Miguel Abboud to Heparin
This is a "connection" page, showing publications Miguel Abboud has written about Heparin.
Connection Strength
0.253
-
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Haematol. 2021 May; 8(5):e334-e343.
Score: 0.175
-
Renal venous thrombosis in a newborn with prothrombotic risk factors. Blood Coagul Fibrinolysis. 2009 Sep; 20(6):458-60.
Score: 0.078